Skip to main content
. 2017 Apr 24;61(5):e00249-17. doi: 10.1128/AAC.00249-17

FIG 1.

FIG 1

(A) Hybrid compounds classified according to (a) mode of interaction of the individual pharmacophores with target, (b) nature/form of presentation, and (c) nature of the linker unit employed. (B) Chemical structures of compounds representing antimalarial hybrids in each category. The chemical structure representing a merged hybrid (F) is that of a potential anticancer agent.